Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Cognizant (Nasdaq: CTSH), a world-leading professional services firm, announced a new collaboration to develop end-to-end digital health solutions that will enable healthcare organizations and life sciences companies to improve patient care and accelerate clinical trials.

Exscientia has received a grant from the Bill & Melinda Gates Foundation and Gates Philanthropy Partners, as part of the COVID-19 Therapeutics Accelerator. This is to expedite the optimisation of a new class of COVID-19 therapeutics created using its artificial intelligence (AI) drug design platform.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced a strategic partnership agreement with NICO.LAB, a MedTech stroke care company. Together with the recently expanded stroke capabilities of Philips Image Guided Therapy System - Azurion - this new partnership significantly advances Philips' commitment to improving outcomes for people who suffer a stroke.

Health and social care secretary Matt Hancock has been abruptly replaced by Sajid Javid. The Highland Marketing advisory board consider the huge agenda he is now facing, and what it could - and should - mean for health tech.

Matt Hancock's downfall as health and social care secretary was swift. On Friday, barely 12-hours after he had delivered the keynote speech to the NHS Confederation’s annual conference, The Sun newspaper published a CCTV grab of him enjoying a "steamy clinch" with an aide.

Scottish health and care professionals across a wide range of clinical settings including NHS Scotland health boards are being given access to an individual's COVID-19 vaccine status through the Orion Health shared care record used in 11 out of the country's 14 health boards.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has participated in an important research project to develop a magnetic resonance (MR) imaging technique [1,2] that could potentially revolutionize the use of MR imaging in cardiology.

Reducing the procedure time for full evaluation of heart anatomy and function from about one hour down to a few minutes, this new technique has the potential to increase patient access to precision diagnosis, improve patient comfort due to shorter scan times, and lower the cost of care.

CSAM Health Group AS ("CSAM"), the leading provider of niche eHealth solutions in the Nordics, today announced it has signed a deal to acquire eHealth player Optima Corporation Ltd from Chicago, USA-based R1 RCM.

With the acquisition of Optima Corporation, CSAM Health Group will bring market-leading Optima products, impressive customer base and skilled teams in Auckland, New Zealand, Chicago, US, and Reading, UK, into the CSAM family.